RAD — Radiopharm Theranostics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Radiopharm Theranostics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	27	11.7	18.6	29.1	4.14
Net Total Accounts Receivable
Net Total Receivables	0.056	4.47	0.987	10.4	17.4
Total Other Current Assets
Total Current Assets	27.3	16.3	22.8	39.9	21.9
Net Property, Plant And Equipment	0.002	0.068	0.061	0.053	0.046
Net Intangible Assets
Long Term Investments
Total Assets	83.4	74.9	72	86.5	60.1
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	7.88	13.2	17.6	14.9	18.9
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	20.4	30.6	43.9	41.7	35.4
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	63	44.4	28.1	44.8	24.7
Total Liabilities & Shareholders' Equity	83.4	74.9	72	86.5	60.1
Total Common Shares Outstanding